{"url_path":"/sec/qlep-un/8-k/2026-05-18/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/2102155/0001213900-26-058447-index.html","accession_number":"0001213900-26-058447","cik":"0002102155","ticker":"QLEP","issuer_name":"Quantum Leap Acquisition Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/2102155/0001213900-26-058447-index.html","primary_entity_key":"0002102155","primary_entity_name":"Quantum Leap Acquisition Corp"},"word_count":260,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n \n\nAs\npreviously reported, on May 4, 2026, Quantum Leap Acquisition Corp (the “Company”) consummated its initial public offering\n(“IPO”) of 20,000,000 units (the “Units”) at a price of $10.00 per Unit, generating gross proceeds to the Company\nof $200,000,000. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary\nShares”), and one redeemable warrant, each warrant exercisable for one Class A Ordinary share, and the conversion of any working\ncapital loans into equity, if elected by the Sponsor (each, a “Warrant”). In connection with the IPO, the Company granted\nthe underwriter a 45-day option to purchase up to an additional 3,000,000 Units at the initial public offering price to cover over-allotments,\nif any.\n\n \n\nOn May 8, 2026, the underwriter\nnotified the Company of their partial exercise of the over-allotment option to purchase an additional 917,392 Units at the initial public\noffering price of $10.00 per Unit, generating additional gross proceeds to the Company of $9,173,920. The partial exercise of the over-allotment\noption closed on May 12, 2026.\n\n \n\nFollowing\nthe closing of the over-allotment option, an aggregate of $211,314,501 is held in the Company’s U.S.-based trust account maintained\nby Continental Stock Transfer & Trust Company, acting as trustee.\n\n \n\nAn\naudited balance sheet as of May 12, 2026 reflecting the receipt of the proceeds from the IPO, the Private Placement and the partial exercise\nof the over-allotment option has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K."}